Does Rallies show Form 4 insider transactions for IMMX?

Yes. Rallies tracks IMMX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is IMMX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IMMX. It does not provide personalized investment advice.

IMMX (Immix Biopharma, Inc. Common Stock) Stock Analysis - Insider Trades

Immix Biopharma, Inc. Common Stock (IMMX) is a publicly traded Healthcare sector company. As of May 21, 2026, IMMX trades at $9.49 with a market cap of $489.16M and a P/E ratio of -9.91. IMMX moved +1.02% today. Year to date, IMMX is +75.29%; over the trailing twelve months it is +323.70%. Its 52-week range spans $1.26 to $11.61. Analyst consensus is strong buy with an average price target of $18.25. Rallies surfaces IMMX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading IMMX stock inside the company?

Recent IMMX insider activity includes Rachman Ilya M bought 746, Morris Gabriel S bought 770, Rachman Ilya M bought 2.50K, Morris Gabriel S bought 2.60K, and Rachman Ilya M bought 2.18K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

IMMX Key Metrics

Key financial metrics for IMMX
Metric	Value
Price	$9.49
Market Cap	$489.16M
P/E Ratio	-9.91
EPS	$-0.89
Dividend Yield	0.00%
52-Week High	$11.61
52-Week Low	$1.26
Volume	448.53K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-29.44M
Gross Margin	0.00%

Recent IMMX Insider Trades

Rachman Ilya M bought 746 (~$4.98K) on Dec 10, 2025.
Morris Gabriel S bought 770 (~$5.07K) on Dec 10, 2025.
Rachman Ilya M bought 2.50K (~$5.05K) on Sep 17, 2025.
Morris Gabriel S bought 2.60K (~$5.12K) on Sep 16, 2025.
Rachman Ilya M bought 2.18K (~$5.00K) on Jun 18, 2025.

Latest IMMX News

Immix Biopharma Achieves 95% CR Rate in 20-Patient NEXICART-2 Trial — May 21, 2026

IMMX Analyst Consensus

4 analysts cover IMMX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.25.

Common questions about IMMX

Who is trading IMMX stock inside the company?: Recent IMMX insider activity includes Rachman Ilya M bought 746, Morris Gabriel S bought 770, Rachman Ilya M bought 2.50K, Morris Gabriel S bought 2.60K, and Rachman Ilya M bought 2.18K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IMMX?: Yes. Rallies tracks IMMX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IMMX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IMMX. It does not provide personalized investment advice.